Working… Menu

Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01649310
Recruitment Status : Unknown
Verified December 2014 by Patrícia Érika de Melo Marinho, Universidade Federal de Pernambuco.
Recruitment status was:  Recruiting
First Posted : July 25, 2012
Last Update Posted : December 3, 2014
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Information provided by (Responsible Party):
Patrícia Érika de Melo Marinho, Universidade Federal de Pernambuco

Brief Summary:

The whole body vibration offers better treatment adherence among the elderly, minimizing effort and additional stress to the cardiovascular system and skeletal muscles compared to conventional exercise programs.

Hypothesis: Patients with COPD undergoing a training program on the whole body vibration show better performance in the 6MWT and improvement in muscle strength.

Condition or disease Intervention/treatment Phase
Chronic Obstructive Pulmonary Disease (COPD) Other: whole body vibration Not Applicable

Detailed Description:

In the elderly and in COPD patients weight loss includes sarcopenia, resulting from aging itself or due to disuse or disease states associated with and represents the reduction in muscle mass, leading to decreased strength and endurance, with repercussions on the functional abilities of the same. It reduces the power and muscle strength with aging which represent decreasing to carry out daily physical tasks.

In COPD, exacerbations worsen the loss of muscle mass, affecting the respiratory and peripheral muscles, exercise capacity and survival rates, and in the case of severe malnutrition in advanced cases of the disease, the implications of this state are disability which occur between 10-15% in those with mild obstruction and 25% in moderate to severe obstructive and are associated with worse prognosis.

The whole body vibration could be an efficient combination of training methods for elderly patients and is based on the generation of sinusoidal vibrations offered by a platform, which stimulates the muscle spindles resulting in activation of neurons α engines and develop muscle contractions, presenting itself as an alternative to conventional treatment for muscular endurance as well as improving physical fitness

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 21 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Effects of Whole Body Vibration Training in Chronic Obstructive Pulmonary Disease (COPD) Patients: a Randomized Controlled Trial
Study Start Date : February 2012
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases

Arm Intervention/treatment
Experimental: WVB Training Other: whole body vibration
Exercises on the platform will be made in semi-squat position, static. In the first month training will be held for 10 minutes for the exercises on the platform, 30 seconds of vibration of low intensity, interspersed with rest 60 seconds while standing beside the platform. In the second month training will be held for 15 minutes, lasting 60 seconds of vibration and 30 seconds of rest in standing beside the platform. For the first two weeks training will have low intensity and the last two weeks training will have higher vibration. In the third month, training will be held for 20 minutes, 60 seconds of vibration and 30 seconds of rest while standing beside the platform. The intensity of the vibration will be high.
Other Name: Equipment: Power Plate my3

Primary Outcome Measures :
  1. Walked distance in 6MWT [ Time Frame: Increase in distance walked at baseline and 3 months ]
    Change from baseline in distance walked test 6-minute walk test at 3 months.

Secondary Outcome Measures :
  1. Respiratory muscle strength [ Time Frame: Change from baseline in respiratory muscle strength at 3 months ]
    Increase in respiratory muscle strength.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Smoking history, occupational or environmental exposure to pollutants and / or cough, hypersecretion or dyspnea,
  • FEV1 <80% predicted and postbronchodilator FEV1/FVC <70% to confirm the diagnosis of airway obstruction air not fully reversible bronchodilator therapy,
  • Have the ability to perform the walk test, 6 minutes, absence of comorbidities that preclude the achievement of effort (hypertension, severe pulmonary hypertension, myocardial infarction, congestive heart failure, severe dyspnea)
  • Preserved cognitive functioning,
  • Clinically stable during the study period

Exclusion Criteria:

  • Have cognitive impairment, hearing or visual compromise the response to the questionnaires used in this study
  • Make modifications to the appliance neuro-musculo-skeletal system that prevents the completion of the 6MWT
  • Be participating in physical activity programs.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01649310

Layout table for location contacts
Contact: Patricia Marinho Patricia Marinho, PhD 55 81 21268496

Layout table for location information
Universidade Federal de Pernambuco Recruiting
Recife, Pernambuco, Brazil, 50.740-560
Contact: Patricia EM Marinho, PhD    8191069204   
Principal Investigator: Patricia EM Marinho, PhD         
Sponsors and Collaborators
Universidade Federal de Pernambuco
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Patrícia Érika de Melo Marinho, Professor, Universidade Federal de Pernambuco Identifier: NCT01649310    
Other Study ID Numbers: Patricia
First Posted: July 25, 2012    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014
Keywords provided by Patrícia Érika de Melo Marinho, Universidade Federal de Pernambuco:
Chronic obstructive pulmonary disease (COPD)
Muscle strenght
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases